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Adipose triglyceride lipase (ATGL) is the rate-limiting
enzyme for triacylglycerol (TAG) hydrolysis in adipo-
cytes. The precise mechanisms whereby ATGL is
regulated remain uncertain. Here, we demonstrate
that a protein encoded by G0/G1 switch gene 2
(G0S2) is a selective regulator of ATGL. G0S2 is
highly expressed in adipose tissue and differentiated
adipocytes. When overexpressed in HeLa cells,
G0S2 localizes to lipid droplets and prevents their
degradation mediated by ATGL. Moreover, G0S2
specifically interacts with ATGL through the hydro-
phobic domain of G0S2 and the patatin-like domain
of ATGL. More importantly, interaction with G0S2
inhibits ATGL TAG hydrolase activity. Knockdown
of endogenous G0S2 accelerates basal and stimu-
lated lipolysis in adipocytes, whereas overexpres-
sion of G0S2 diminishes the rate of lipolysis in both
adipocytes and adipose tissue explants. Thus,
G0S2 functions to attenuate ATGL action both
in vitro and in vivo and by this mechanism regulates
TAG hydrolysis.
INTRODUCTION
During instances of heightened metabolic demand, triacylgly-
cerol (TAG) stores in lipid droplets of adipocytes undergo
a hydrolytic process (lipolysis) to release free fatty acids (FFAs)
and glycerol into the circulation for use by other organs (Duncan
et al., 2007). The regulation of lipolysis in adipocytes has been
well studied for nearly half of a century, with most of the attention
focused on hormone-sensitive lipase. In a well-established
model, the cAMP-dependent protein kinase (PKA) phosphory-
lates hormone-sensitive lipase (HSL) and the lipid droplet coat
protein perilipin A in response to b-adrenergic hormones.
Consequently, HSL translocates from the cytoplasm onto lipid194 Cell Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc.droplets, thereby mediating TAG hydrolysis (Egan et al., 1992;
Sztalryd et al., 2003). However, the failure of HSL null mice to
display an obese phenotype led to the discovery of an indepen-
dent TAG hydrolase named adipose triglyceride lipase (ATGL)
(Jenkins et al., 2004; Villena et al., 2004; Zimmermann et al.,
2004). The complete lipolysis in adipocytes is delicately regu-
lated and is now believed to be catalyzed sequentially by
ATGL, HSL, and monoacylglycerol (MAG) lipase (Raben and
Baldassare, 2005; Watt and Steinberg, 2008; Zechner et al.,
2009; Zimmermann et al., 2009).
ATGL is highly expressed in adipose tissue (Villena et al.,
2004; Zimmermann et al., 2004). Its TAG hydrolase activity is
dependent on a ‘‘patatin domain’’ common to plant acyl-trans-
ferases (Dessen et al., 1999; Rydel et al., 2003). Analysis using
cultured cells demonstrated that ATGL was involved in basal
and hormone-stimulated lipolysis in adipocytes (Bezaire
et al., 2009; Kershaw et al., 2006; Zimmermann et al., 2004)
and lipid droplet degradation in nonadipocyte cells (Smirnova
et al., 2006). Most notably, ATGL null mice showed impaired
lipolysis in adipocytes in response to b-adrenergic stimulation
accompanied by an expanded adipose tissue mass and
increased TAG deposition in most other tissues (Haemmerle
et al., 2006). Exercise-induced lipolysis was also shown to
be blunted in these mice (Huijsman et al., 2009). Conversely,
adipose-specific overexpression of ATGL promoted lipolysis
and attenuated diet-induced obesity in mice (Ahmadian
et al., 2009). In humans, a subgroup of neutral lipid storage
disease (NLSD) characterized by mild myopathy was reported
to be caused by mutations in ATGL (Fischer et al., 2007).
Although experiments using a specific HSL inhibitor and
siRNA-mediated knockdown of ATGL suggested that HSL
might be more important in mediating hormone-stimulated
lipolysis in human fat (Langin et al., 2005; Ryde´n et al.,
2007), a very recent study provided evidence that, in human
adipose tissue-derived multipotent stem cell (hMADS) adipo-
cytes, ATGL acted independently of HSL and preceded its
action in the sequential hydrolysis of TAG (Bezaire et al.,
2009). Collectively, these studies have provided compelling
evidence to establish ATGL as the key enzyme catalyzing
adipocyte lipolysis.
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Figure 1. Regulation of G0S2 Protein
Expression
(A) Tissue distribution of G0S2 protein by immuno-
blotting analysis. 1, epididymal white adipose
tissue; 2, interscapular brown adipose tissue; 3,
heart; 4, skeletal muscle (hindlimb, upper-leg
muscle); 5, liver; 6, lung; 7, spleen; 8, pancreas;
9, kidney. b-tubulin was used as a loading control.
(B) Expression of G0S2 protein was analyzed by
immunoblotting in lysates from differentiated
3T3-L1 and T37i adipocytes. Day 1 represents
undifferentiated preadipocytes. aP2 was used
as an adipocytes differentiation marker. UCP1
was used as a brown adipocyte specific marker.
b-actin was used as a loading control.
(C) Immunoprecipitation was performed in
extracts (equal amount of total protein) of mouse
epididymal adipose using either anti-G0S2 serum
(+) or preimmune serum (). G0S2 in the immuno-
precipitates were analyzed by immunoblotting.
Mice used are wild-type mice (wt) and db/db
mice on normal chow and wild-type mice fed
with high-fat diet for 8 weeks (wt/HFD).
(D) Following 4 hr serum deprivation, 3T3-L1 and
T37i adipocytes were treated for 8 hr with 50 nM
insulin (In), 10 nM triiodothyronine (T3), 10 mM
GW501516 (GW), 1 mM rosiglitazone (Rosi), 1 mM
isoproterenol/0.25 mM IBMX (Iso) or 20 ng/ml
TNFa in serum-free medium. Immunoblotting
was performed to detect the levels of G0S2 in
the cell lysates, using b-actin as a loading control.
Cell Metabolism
G0S2 Controls ATGL Activity and TAG HydrolysisIn contrast to HSL, relatively little is known about the mecha-
nisms whereby ATGL activity is regulated. Lass et al. demon-
strated that comparative gene identification-58 (CGI-58) stimu-
lates lipolysis and is an activator of ATGL, but not HSL (Lass
et al., 2006). Earlier studies identified mutations in the human
CGI-58 gene as a cause for Chanarin-Dorfman syndrome
(CDS), a rare form of NLSD characterized by ichthyosis (Lefe`vre
et al., 2001). Of interest, CGI-58 mutants associated with CDS
failed to activate ATGL (Lass et al., 2006), implying that loss of
ATGL activation may be involved in the pathogenesis of CDS.
Moreover, ATGL was shown to interact physically with pigment
epithelium-derived factor (PEDF) in liver (Chung et al., 2008;
Notari et al., 2006). PEDF-deficient hepatocytes exhibited
increased TAG accumulation, suggesting that PEDF also plays
a positive role in regulating ATGL-mediated lipolysis. Further-
more, ATGL activity in adipocytes is known to be promoted by
b-adrenergic stimulation (Haemmerle et al., 2006; Zimmermann
et al., 2009). Although PKA does not appear to directly phos-
phorylate ATGL (Zimmermann et al., 2004), recent work by
Miyoshi et al. demonstrated that phosphorylation of Ser517 in
perilipin A was essential for activation of ATGL in vivo (Miyoshi
et al., 2007).
Here, we demonstrate that G0/G1 switch gene 2 (G0S2),
a protein whose function was previously unclear, is, in fact,
a negative regulator of ATGL. G0S2 was originally identified in
blood mononuclear cells due to the association of its mRNA
expression with re-entry of cells from G0 into G1 phase (Russell
and Forsdyke, 1991). However, its role in cell-cycle regulation
has never been established. Zandbergen et al. later reportedCethat the G0S2 mRNA level was highest in adipose tissue and
was upregulated during adipogenic differentiation of preadipo-
cytes (Zandbergen et al., 2005). In this study, we performed
functional analysis of G0S2 by using a variety of in vitro and
cell-based approaches. Our results indicate that G0S2 binds
directly to ATGL and is capable of attenuating ATGL-mediated
lipolysis via inhibiting its TAG hydrolase activity.
RESULTS
Expression Pattern of G0S2 Protein
To initiate functional studies, we raised antibodies against
murine G0S2 (Figure S1 available online) and determined its
expression pattern. Immunoblotting of various mouse tissues
demonstrated an abundant expression of G0S2 in white and
brown adipose tissues (WAT and BAT) and liver and, to a lesser
degree, in heart (Figure 1A). The adipose-specific expression of
G0S2 was corroborated in mouse white 3T3-L1 and brown T37i
preadipocyte cell lines (Figure 1B). In both cell types, G0S2
protein expression was first detected 4 days after adipogenic
induction. The maximal level was reached after 7 days, when
3T3-L1 cells were fully differentiated, as judged by expression
of an adipocyte marker aP2. In T37i cells, the G0S2 expression
became robust after 5 days. UCP1, a brown adipocyte-specific
mitochondrial marker, appeared at the 7 day time point. These
results indicate a differentiation-dependent expression of
G0S2 protein in adipocytes. In mouse WAT, amounts of G0S2
were significantly decreased in db/db mice compared with
that of wild-type mice (Figure 1C). Chronic high-fat feeding ofll Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc. 195
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G0S2 G0S2/BODIPY EnlargedA Figure 2. G0S2 Inhibits Lipid Droplet Degra-dation Mediated by ATGL
(A) Immunofluorescence staining with anti-G0S2
antibodies was performed to reveal localization
of overexpressed untagged G0S2 in HeLa cells.
Lipid droplets were costained with BODIPY 493/
503 fluorescence dye.
(B) HeLa cells transfected with ATGL in the
absence (top) or presence (bottom) of G0S2-
FLAG were incubated under normal growth condi-
tions with 400 mM of oleic acid complexed to
albumin for 3 hr. Immunofluorescence staining
was performed by using anti-ATGL (red) and
anti-FLAG (blue) antibodies. Lipid droplets were
costained with BODIPY 493/503 fluorescence
dye.
(C and D) Stable HeLa cell clones with or without
untagged G0S2 expression were treated with
ATGL siRNA (ATGL KD) or control mismatch
siRNA (Ctrl KD). Protein expression was analyzed
by immunoblotting with anti-ATGL and anti-
G0S2 antibodies (C). The cells were incubated in
400 mM of oleic acid for 3 hr, and the intracellular
TAG content was determined as described in
Experimental Procedures. The data were normal-
ized with the total protein amounts in the cell
extracts (D).
Data are shown as mean ± SD and represent three
independent experiments. **p < 0.01, t test.
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G0S2 Controls ATGL Activity and TAG Hydrolysiswild-type mice also reduced the level of G0S2 in WAT, suggest-
ing that G0S2 expression negatively correlates with the develop-
ment of obesity.
Treatment with insulin profoundly increased G0S2 expression
in both 3T3-L1 and T37i adipocytes (Figure 1D). Conversely,
prolonged treatment with b-adrenergic agonist isoproterenol or
another lipolysis-inducing hormone TNFa drastically decreased
G0S2 level in both cell types. Moreover, no effects were
observed when adipocytes were treated with GW501516
(a PPARd ligand) or T3 (thyroid hormone). Rosiglitazone, how-
ever, significantly enhanced G0S2 expression in both cell
types, confirming that G0S2 is a PPARg downstream target
(Zandbergen et al., 2005).
G0S2 Prevents Lipid Droplet Turnover Mediated
by ATGL
To obtain further insight into the potential function of G0S2, we
expressed G0S2 in HeLa cells and determined its subcellular196 Cell Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc.localization by immunofluorescence
staining. As shown in Figure 2A, G0S2
displayed a pattern of small rings that
scattered throughout the cytoplasm.
Using BODIPY 493/503, a nonpolar probe
selective for neural lipids such as TAG, we
identified that these ring-like structures
surrounded the central cores of lipid
droplets. Because lipid droplets undergo
constant synthesis and turnover (Martin
and Parton, 2006), we next examined
the potential involvement of G0S2 in
regulating lipid droplet stability. HeLacells transiently expressing G0S2 were treated with oleic acid
for 3 hr to promote lipid droplet formation (Figure S2A). Lipid
droplets in cells expressing G0S2 were significantly larger and
more numerous than those in the neighboring untransfected
cells (Figure S2A, top). Overloading the cells with oleic acid for
24 hr resulted in accumulation of large lipid droplets in both
transfected and untransfected cells, with no obvious difference
in size and number (Figure S2A, middle). However, after 24 hr
of oleic acid treatment followed by nutrient starvation for 4 hr,
lipid droplets in untransfected cells underwent pronounced
degradation while overexpression of G0S2 was able to prevent
such turnover (Figure S2A, bottom). For the three experimental
conditions employed, the average diameter of lipid droplets in
untransfected cells versus G0S2-transfected cells was 0.45 mm
versus 0.89 mm, 1.13 mm versus 1.22 mm, and 0.34 mm versus
0.99 mm, respectively (Figure S2B).
Because ATGL plays a key role in lipid droplet degradation in
HeLa cells (Smirnova et al., 2006), we tested whether G0S2
Cell Metabolism
G0S2 Controls ATGL Activity and TAG Hydrolysiswould neutralize this effect of ATGL action. Upon oleic acid
loading, HeLa cells transfected with ATGL alone showed a
marked reduction in both size and number of lipid droplets
compared with the adjacent untransfected controls (Figure 2B,
top). Interestingly, coexpression of G0S2 tagged at the C
terminus with a FLAG epitope (G0S2-FLAG) was able to reverse
this effect of ATGL overexpression (Figure 2B, middle). Conse-
quently, G0S2-FLAG and ATGL were found to be colocalized
at the surface of lipid droplets (Figure 2B, bottom). To further
assess whether G0S2 and ATGL, singly or in combination, affect
intracellular TAG accumulation, we generated HeLa cells stably
expressing untagged G0S2 and then employed siRNA to knock
down ATGL in these cells. The knockdown was equally effective
at reducing endogenous ATGL in both G0S2-expressing and
nonexpressing cells (Figure 2C). Less than 5% of ATGL was
present in cells transfected with a pool of siRNAs directed
against ATGL compared with cells transfected with a mis-
matched control siRNA. The TAG content in G0S2-expressing
cells was profoundly increased upon oleic acid treatment
compared with that in nonexpressing control cells (Figure 2D).
Knockdown of ATGL promoted TAG accumulation in control
cells, presumably due to decreased TAG hydrolysis. Strikingly,
the effects of reduced ATGL expression and G0S2 overexpres-
sion are not additive because ATGL knockdown failed to further
increase the TAG content in G0S2-expressing cells (Figure 2D).
Taken together, these results suggest that G0S2 expression
may stabilize lipid droplets and promote TAG accumulation via
inhibiting ATGL-catalyzed lipolysis.
G0S2 Inhibits TAG Hydrolase Activity of ATGL
Murine G0S2 is a 103 amino acid protein with a central putative
hydrophobic domain (residues 27–42) (Zandbergen et al., 2005).
ATGL, on the other hand, belongs to a family of lipases contain-
ing a patatin domain essential for their hydrolase activity (Watt
and Steinberg, 2008; Zimmermann et al., 2009). The C-terminal
region of ATGL contains a putative lipid-binding domain that is
highly hydrophobic (Fischer et al., 2007; Kobayashi et al.,
2008; Schweiger et al., 2008) (Figure 3A). To determine whether
G0S2 could regulate TAG hydrolase activity of ATGL, we trans-
fected ATGL in G0S2-expressing or nonexpressing HeLa cells
(Figure 3B). In assays with lysates of nonexpressing control cells,
transfection of ATGL resulted in a > 4-fold increase in the TAG
hydrolase activity when compared to transfection of vector
alone. By contrast, overexpression of ATGL in G0S2-expressing
cells failed to significantly enhance the lipase activity. G0S2 also
significantly reduced the activity of ATGLDHD, a mutant that
lacks the putative lipid-binding hydrophobic domain (Figure 3B).
As a control, expression of HSL increased lipase activity by
10-fold independently of G0S2 expression (Figure S3). There-
fore, the presence of G0S2 substantially inhibits the enzymatic
activity of ATGL, but not that of HSL.
Because ATGL is activated by CGI-58 (Lass et al., 2006), we
investigated whether G0S2 could affect the TAG hydrolase
activity of ATGL in the presence of CGI-58. To this end, ATGL,
CGI-58, and G0S2 were expressed singly in HeLa cells, and
then the TAG hydrolase activity was measured in combined
cell extracts (Figure 3C). The addition of CGI-58-containing
extracts to ATGL-containing extracts caused an 4-fold
increase in the TAG hydrolase activity. However, the furtherCeaddition of G0S2-containing extracts to the mixture considerably
eliminated this activating effect of CGI-58, indicating that G0S2
is capable of inhibiting ATGL even in the presence of CGI-58.
Similar results were obtained by adding recombinant G0S2
protein expressed and purified from E. coli to ATGL and
CGI-58 produced from an in vitro transcription/translation
system. As shown in Figure 3D, purified G0S2 dose dependently
inhibited the TAG hydrolase activity of ATGL in both the absence
and presence of CGI-58. Moreover, varying amounts of purified
G0S2 were added to mouse WAT and BAT extracts, with the
highest concentration decreasing their total TAG hydrolase
activity by 32% and 38%, respectively (Figure 3E). The differ-
ences are significant considering that, although ATGL is the
main TAG hydrolase in vivo, a large portion of the total in vitro
activity toward TAG substrate is accounted for by HSL and
therefore may not be affected by G0S2.
G0S2 Directly Interacts with ATGL
To determine whether G0S2 physically interacts with ATGL, we
transiently expressed ATGL and G0S2-FLAG in HeLa cells and
evaluated their interaction by coimmunoprecipitation assays
(Figure 4A). As revealed by immunoblotting of total proteins
from cell lysates, comparable levels of ATGL were expressed
with or without G0S2-FLAG. Anti-FLAG immunoprecipitation
demonstrated a specific association of ATGL with precipitated
G0S2-FLAG. To identify the structural determinants required
for the G0S2-ATGL interaction, we generated several deletion
mutants of G0S2 and ATGL (Figure 3A). Whereas G0S21–73
contains the N-terminal 73 amino acids including an intact
hydrophobic domain, G0S2DHD is an internal deletion mutant
lacking the hydrophobic domain. Meanwhile, ATGLDPT and
ATGLDHD are two internal deletion mutants that lack the
patatin domain (residues 10–178) and the hydrophobic domain
(residues 259–337), respectively. As shown in Figure 4A,
G0S2-FLAG coimmunoprecipitated with both wild-type ATGL
and ATGLDHD mutant, whereas ATGLDPT mutant exhibited
no interaction with G0S2-FLAG. In a separate experiment,
G0S21-73-FLAG was found to interact with ATGL with the same
affinity as the full-length G0S2-FLAG. However, G0S2DHD-
FLAG showed no binding to ATGL (Figure 4B). Therefore, the
hydrophobic domain in G0S2 and the patatin domain of ATGL
are needed for mediating the specific association.
To determine whether interaction occurs between the endog-
enous proteins, ATGL was immunoprecipitated from 3T3-L1
adipocyte lysates with anti-ATGL antibodies. As controls, immu-
noprecipitation was performed using nonspecific or anti-HSL
antibodies, as well as using ATGL antibodies in the presence
of an ATGL-blocking peptide. As shown in Figure 4C, endoge-
nous ATGL and HSL were efficiently pulled down by respective
antibodies. G0S2 was specifically coimmunoprecipitated with
ATGL, but not with HSL. The blocking peptide was able to
abolish both immunoprecipitation of ATGL and coimmunopreci-
pitation of G0S2 by ATGL antibodies, demonstrating the speci-
ficity of their association. The complex formation appears to be
stable because pretreatment of cells with either isoproterenol
or insulin conferred no significant impact on the G0S2-ATGL
coimmunoprecipitation (Figure 4C).
To exclude the possibility that the complex formation is
bridged by a third protein in cells, we assayed the interactionll Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc. 197
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Figure 3. G0S2 Selectively Inhibits the TAG Hydrolase Activity of ATGL
(A) Schematic structures of generated mutants of murine G0S2 and ATGL. The location of the hydrophobic domain (HD) in both proteins is indicated as gray bars,
and the patatin domain (PT) in ATGL is indicated by a black region.
(B) HeLa cells from control clone or G0S2-expressing clone were transfected with vector alone, ATGL, and ATGLDHD. At 24 hr after transfection, ATGL and G0S2
proteins were detected with anti-ATGL and anti-G0S2 antibodies in immunoblotting using cell extracts. TAG hydrolase activity in cell extracts was measured
using 3H-labeled triolein as substrate and was normalized with the total protein levels of the cell extracts.
(C) Extracts of HeLa cells singly expressing ATGL, CGI-58, or G0S2 were mixed in various combinations, and TAG hydrolase activity was determined. Proteins in
parallel mixtures were revealed in immunoblotting.
(D) ATGL and CGI-58 produced by using in vitro translation system were mixed with increasing amounts of purified recombinant G0S2 and were subjected to TAG
hydrolase activity assays.
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G0S2 Controls ATGL Activity and TAG Hydrolysisbetween G0S2 and ATGL proteins produced by in vitro transcrip-
tion/translation system (Figure 4D). As expected, ATGL was
coimmunoprecipitated with G0S2-FLAG when they were present
in the same reaction, demonstrating a direct association in vitro.
The association with ATGL required the hydrophobic domain of
G0S2 because ATGL did not coprecipitate with an internal
deletion mutant of G0S2 (G0S2DHD-FLAG) (Figure 4D). In addi-
tion, we analyzed the TAG hydrolase activity in reaction mixtures
containing ATGL with wild-type G0S2-FLAG or G0S2DHD-FLAG
(Figure 4E). G0S2-FLAG decreased the TAG hydrolase activity in
ATGL-containing mixture by 70%, whereas G0S2DHD-FLAG
had no significant effect, indicating that direct interaction is
necessary for efficient inhibition of ATGL by G0S2.
Lipid Droplet Localization of G0S2 in Adipocytes
Depends on Interaction with ATGL
ATGL activity in vivo is determined by its lipid droplet localization
(Fischer et al., 2007; Kobayashi et al., 2008; Schweiger et al.,
2008). To analyze the relative localization of endogenous ATGL
and G0S2, we performed lipid droplet fractionation experiments
using 3T3-L1 adipocytes (Figure 5A). In basal state, only low
levels of HSL, ATGL, and G0S2 were detected in the association
with lipid droplets. Insulin treatment mildly increased the
amounts of ATGL and G0S2, but not HSL, in the lipid droplet
fraction. As expected, stimulation of lipolysis with isoproterenol
promoted translocation of HSL to lipid droplet fraction where
upward shift of perilipin was also observed due to PKA phos-
phorylation. Of interest, isoproterenol also caused a marked
movement of both ATGL and G0S2 to lipid droplets
(Figure 5A). A time course experiment showed a rapid and sus-
tained accumulation of ATGL and G0S2 in lipid droplets over
the course of 10–120 min poststimulation (Figure S4). Lipid
droplet translocation of ATGL and G0S2 was independently con-
firmed by immunofluorescence microscopy, as isoproterenol
caused redistribution of ATGL and G0S2 staining from cyto-
plasm to rim-like structures surrounding lipid droplets
(Figure 5B). To determine whether G0S2 moves onto lipid drop-
lets in a complex with ATGL, we tested the effect of ATGL knock-
down on the lipid droplets translocation of G0S2. As revealed by
immunoblotting in Figure 5C, an 90% knockdown efficiency
was achieved by the combined usage of a pool of siRNAs
against murine ATGL in comparison to mismatched controls.
Of interest, knockdown of ATGL expression reduced the overall
level of G0S2 protein while having no effect on the expression of
HSL and perilipin. More importantly, G0S2 was absent in the lipid
droplet fraction isolated from isoproterenol-treated cells trans-
fected with ATGL siRNA (Figure 5C), suggesting that the lipid
droplet localization of G0S2 may indeed depend on its interac-
tion with ATGL.
G0S2 Attenuates Lipolysis in Adipocytes
The findings that G0S2 interacts with and inhibits ATGL promp-
ted us to investigate the potential role of G0S2 in adipocyte
lipolysis. To this end, we reduced the G0S2 level in 3T3-L1
adipocytes by siRNA-mediated knockdown. Compared with(E) Increasing amounts of recombinant purified G0S2 was added to extracts (100 m
hydrolase activity was determined.
All data are shown as mean ± SD and represent three independent experiments
Cemismatch control siRNA, the siRNA directed against G0S2 was
effective at inhibiting G0S2 expression in 3T3-L1 adipocytes
(Figure 6A). Importantly, lipolysis in 3T3-L1 cells was significantly
enhanced by G0S2 knockdown in a time-dependent manner.
After a 2 hr incubation period, basal and isoproterenol-stimu-
lated FFA release was increased by 103% and 75%, respectively
(Figure 6A). The effect of G0S2 knockdown on glycerol release
followed the same trend, though it was less prominent
(Figure 6A).
To corroborate our knockdown results, we performed gain-of-
function studies by infecting adipocytes with an adenovirus
encoding murine G0S2 (Ad-G0S2). Two different dosages of
Ad-G0S2 and a null virus were employed, with the higher dose
of Ad-G0S2 achieving an 4-fold increase in G0S2 expression
in 3T3-L1 adipocytes (Figure 6B). Infection of 3T3-L1 cells with
Ad-G0S2 at this higher dosage significantly reduced basal and
stimulated lipolysis when compared to infection with the null
virus. In addition, infection of WAT explants with Ad-G0S2 virus
inhibited isoproterenol-stimulated FFA release by 40% (Fig-
ure 6C). However, ectopic expression of G0S2 in WAT explants
only had a mild effect on basal FFA release. Nonetheless, these
results collectively demonstrate a critical role of G0S2 in the
control of adipose lipolysis.
DISCUSSION
As a closely controlled process essential for survival, lipolysis in
adipocytes has been well studied for several decades. The
discovery of ATGL as the key enzyme in adipocyte lipolysis is
relatively recent (Zimmermann et al., 2009), and how ATGL
activity is regulated is mostly unknown. The present study
provides compelling evidence that G0S2 is an important nega-
tive regulator of ATGL-mediated lipolysis. Like ATGL (Figures
1A and 1B) (Villena et al., 2004; Zimmermann et al., 2004),
G0S2 protein is highly expressed in adipose tissue, and its
expression was induced during adipocyte differentiation. Bio-
chemically, G0S2 binds directly to ATGL and is capable of
inhibiting its TAG hydrolase activity. Functionally, overexpres-
sion of G0S2 prevents ATGL-mediated lipid droplet degradation
in HeLa cells, as well as basal and stimulated lipolysis in cultured
adipocytes and fat explants. Knockdown of endogenous G0S2,
on the other hand, enhances adipocyte lipolysis under the same
conditions.
G0S2 is a small basic protein with 78% identity between
mouse and human isoforms. It has no homologs in lower organ-
isms such as Caenorhabditis elegans and Drosophila. Our dele-
tion mutagenesis experiments showed that the putative hydro-
phobic domain of G0S2 and the catalytic patatin-like domain
of ATGL were responsible for mediating their specific interaction.
Moreover, knockdown of ATGL decreased the overall content of
G0S2 in adipocytes, indicating that intracellular stability of G0S2
may be enhanced by its interaction with ATGL. Although detailed
structural studies are needed to delineate the possible mecha-
nisms for inhibition of ATGL lipase activity by G0S2, we specu-
late that G0S2 binding may directly affect the substrate (TAG)g total protein) of epididymal (WAT) and interscapular (BAT) fat tissue, and TAG
. *p < 0.05, **p < 0.01, and ***p < 0.001, t test.
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Figure 4. G0S2 Specifically Interacts with ATGL
(A) HeLa cells were cotransfected with vector alone or G0S2-FLAG together with different ATGL constructs (1, ATGL+vector; 2, ATGL+G0S2-FLAG;
3, ATGLDHD+vector; 4, ATGLDHD+G0S2-FLAG; 5, ATGLDPT+vector; 6, ATGLDPT+G0S2-FLAG). G0S2-FLAG proteins were immunoprecipitated with anti-
FLAG antibodies. G0S2 and ATGL proteins in immunoprecipitates and lysates were detected by immunoblotting with FLAG and ATGL antibodies.
(B) HeLa cells were cotransfected with wild-type ATGL along with vector alone or various G0S2-FLAG constructs. Immunoprecipitation and immunoblotting anal-
ysis were performed as described in (A).
(C) 3T3-L1 adipocytes were pretreated with or without 1 mM isoproterenol or 100 nM insulin for 30 min. Immunoprecipitation of endogenous ATGL was performed
in the lysates in the presence or absence of an ATGL epitope-blocking peptide. Nonspecific control and HSL antibodies were used as controls. G0S2, ATGL, and
HSL in precipitates and lysates were analyzed by immunoblotting with respective antibodies.
(D) Anti-FLAG immunoprecipitation was performed following the in vitro transcription/translation reactions. ATGL and FLAG-tagged G0S2 proteins in precipitates
were analyzed by immunoblotting with anti-ATGL and anti-FLAG antibodies.
(E) The TAG hydrolase activity in the in vitro transcription/translation mixtures was measured using 3H-labeled triolein as substrate. The activity was normalized
with the total protein levels of the reaction mixtures and is shown in relation to basal activity detected in reactions containing vector alone.
Data are shown as mean ± SD and represent three independent experiments. **p < 0.01, t test.
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Aside from being a TAG hydrolase, ATGL possesses activity as
an acyl-CoA-independent transacylase, utilizing acylglycerols
such as mono-olein or diolein as acyl donors/acceptors in the
production of TAG (Jenkins et al., 2004). Therefore, it is also
possible that the G0S2 binding can decrease the net fatty acid200 Cell Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc.release in a futile cycle by promoting ATGL-mediated transacy-
lation of DAG and MAG back to TAG. Furthermore, we found
that G0S2 was capable of dose dependently inhibiting ATGL
even in the presence of the coactivator CGI-58, though CGI-58
rendered ATGL less sensitive to G0S2 inhibition. Because
CGI-58 binds to the same N-terminal region of ATGL (Lass
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Figure 5. Lipid Droplet Localization of ATGL
and G0S2 in Adipocytes
(A) 3T3 L1 adipocytes were treated with or without
1 mM isoproterenol/0.25 mM IBMX or insulin for
30 min. Lipid droplets were isolated by ultracentri-
fugation. Total and lipid droplet-associated
proteins were subjected to immunoblotting using
antibodies against ATGL, perilipin, HSL, G0S2,
and aP2.
(B) Immunofluorescence staining with anti-ATGL
antibodies was performed to reveal localization
of endogenous ATGL in 3T3-L1 adipocytes pre-
treated with or without 1 mM isoproterenol/
0.25 mM IBMX for 30 min. Lipid droplets were
costained with BODIPY 493/503.
(C) siRNA-mediated knockdown was performed
by electroporating 3T3-L1 adipocytes with either
control siRNA (Ctrl) or ATGL-specific siRNA (KD).
Three days later, cells were treated with or without
1 mM isoproterenol/0.25 mM IBMX for 30 min fol-
lowed by lipid droplets isolation. Total and lipid
droplet-associated levels of ATGL, HSL, G0S2,
and perilipin were analyzed by immunoblotting.
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G0S2 Controls ATGL Activity and TAG Hydrolysiset al., 2006; Schweiger et al., 2008), it would be interesting to
determine whether CGI-58 and G0S2 directly compete with
each other in the control of ATGL lipase activity.
The expression of G0S2 is subject to hormonal and nutritional
regulation. Previous studies have shown that G0S2 mRNA level
is upregulated by insulin in skeletal muscle (Parikh et al., 2007),
by glucose in liver (Ma et al., 2006), and by PPARg agonists in
adipocytes (Zandbergen et al., 2005), indicating its role in energy
metabolism. We found that G0S2 in adipocytes was reciprocally
regulated by insulin and lipolytic stimulators. In contrast to
reduced expression of ATGL (Figure 1D) (Kershaw et al., 2006),
prolonged insulin treatment significantly upregulated G0S2
protein expression in adipocytes. Chronic treatment with isopro-
terenol and TNFa, on the other hand, drastically downregulated
the level of G0S2. The fact that the expression of G0S2 as a
lipolytic inhibitor can alter according to anabolic versus catabolic
conditions implicates a potential mechanism to switch the
balance between TAG mobilization and storage. In cases of
caloric surplus, for example, an insulin-induced increase in theCell Metabolism 11, 194–2ratio between G0S2 and ATGL levels
may lead to lower lipolytic capacity and
thus serve to facilitate the flow of fatty
acid into TAG in WAT. During chronic
exposure to starvation, catecholamines
can turn off the expression of G0S2 as
a way to sustain lipolysis in adipocytes.
By both lipid droplet fractionation
and immunofluorescence staining, we
demonstrated that isoproterenol treat-
ment promoted rapid and dramatic trans-
location of ATGL from cytoplasm to the
surface of lipid droplets. The observation
that ATGL underwent HSL-like transloca-
tion to lipid droplets in response to lipo-
lytic stimulation is potentially very impor-
tant. The ATGL enzyme action, which isdependent on its lipid droplet localization, is known to be sensi-
tive to b-adrenergic stimulation in adipocytes (Zimmermann
et al., 2009). However, unlike HSL, ATGL activity does not
appear to be regulated directly by PKA phosphorylation (Zim-
mermann et al., 2004). Two previous studies demonstrated
either a modest or no translocation of ATGL to lipid droplets in
lipolytically stimulated cells (Granneman et al., 2007; Zimmer-
mann et al., 2004). This discrepancy from our findings may be
due to the fact that the previous experiments employed transient
overexpression of epitope-tagged proteins, whereas our obser-
vations were made on endogenous ATGL. Similarly, Bezaire
et al. showed that forskolin stimulated translocation of both
HSL and ATGL to lipid droplets in human hMADs adipocytes
(Bezaire et al., 2009). Together, these findings implicate a poten-
tial mechanism for the activation of ATGL in vivo in response to
b-adrenergic stimulation. Of interest, Miyoshi et al. showed
that ATGL action in adipocytes was controlled by PKA phos-
phorylation of Serine 517 of perilipin A (Miyoshi et al., 2007).
Therefore, it would be tempting to examine whether this05, March 3, 2010 ª2010 Elsevier Inc. 201
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Figure 6. G0S2 Attenuates Basal and Stimulated Lipolysis in Adipocytes
(A) siRNA-mediated knockdown of G0S2 in 3T3-L1 adipocytes was achieved by electroporating cells with either control siRNA or G0S2-specific siRNA. Cells
were treated 3 days later with (stimulated) or without (basal) 1 mM isoproterenol for 30 min, 60 min, and 2 hr. Basal and stimulated FFA and glycerol release
were measured and normalized with the total protein levels in the cell extracts. Expression of G0S2 protein was analyzed by immunoblotting, using b-actin
as a loading control. Data are shown as mean ± SD and represent three independent experiments. *p < 0.05 and **p < 0.01, one-way ANOVA.
(B) Overexpression of G0S2 in 3T3-L1 adipocytes was achieved by infecting cells with recombinant adenovirus encoding murine G0S2 (Ad-G0S2). A null virus was
used as a control. G0S2 expression was analyzed by immunoblotting 3 days after infection. 1, null virus at high dosage; 2, null virus at low dosage; 3, Ad-G0S2 at
high dosage; 4, Ad-G0S2 at low dosage. Three days following infection with either null or Ad-G0S2 at high dosage, lipolysis of 3T3-L1 adipocytes was measured as
described in A. Data are shown as mean ± SD and represent three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001, one-way ANOVA.
(C) Overexpression of G0S2 in gonadal fat explants was achieved by infection with Ad-G0S2 using null virus as a control. At 2 days postinfection, explants were
treated with (stimulated) or without (basal) 1 mM isoproterenol for 2 hr. Basal and stimulated FFA release was measured and normalized with the total mass of
explants. Data are shown as mean ± SD and represent three independent experiments. **p < 0.01, t test.
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Figure 7. Model for the Regulation of
Adipose Lipolysis by G0S2
Under basal conditions when the lipolytic rate is
very low, ATGL is mostly localized in ER-related
membranes in the cytoplasm. At least a small
fraction of ATGL is in complex with G0S2. Upon
b-adrenergic stimulation, PKA activation results
in phosphorylation of perilipin A at multiple
sites. Consequently, ATGL, both G0S2-bound
and -unbound form, undergoes translocation
onto lipid droplets. Translocation of unbound
ATGL along with HSL leads to acute activation of
TAG hydrolysis. Prolonged b-adrenergic stimula-
tion subsequently downregulates protein level of
G0S2, thereby releasing more ATGL for sustained
lipolysis.
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G0S2 Controls ATGL Activity and TAG Hydrolysisphosphorylation event plays any role in the redistribution of
ATGL to lipid droplets. Also worth mentioning is a mild accumu-
lation of ATGL and G0S2 in lipid droplets induced by insulin
treatment of adipocytes. The precise signaling mechanisms
and functional relevance of this observation are currently
unknown. We speculate that ATGL, some of which is in the
form of ATGL/G0S2 complex, may move onto lipid droplets as
a feedback response to lipolytic inhibition or/and lipogenic stim-
ulation elicited by insulin. Prolonged insulin treatment is able to
downregulate ATGL expression, thereby reversing this process.
As revealed by coimmunoprecipitation, the interaction
between ATGL and G0S2 was not subject to regulation by
isoproterenol. Based upon this observation, we speculate that
at least a small fraction of ATGL is constantly in complex with
G0S2, both in the basal state and during the acute stage of lipo-
lytic stimulation. Although G0S2-bound ATGL is not fully active, it
is conceivable that not all ATGL is in association with G0S2, and
isoproterenol-stimulated translocation of this free fraction would
still allow profound activation of lipolysis (Figure 7). Two lines of
evidence that we obtained are supportive of this hypothesis.
First, G0S2 underwent similar translocation from cytoplasm to
lipid droplets upon isoproterenol treatment. This redistribution
was abolished by the knockdown of ATGL, indicating that
G0S2 is piggybacked onto lipid droplets by ATGL. The result is
consistent with our other finding that the G0S2 binding does
not involve the lipid-binding hydrophobic domain of ATGL,
allowing simultaneous association of ATGL to G0S2 and lipid
droplets. Second, through knockdown and overexpression of
G0S2, thereby altering the ratio between free ATGL and G0S2-
bound ATGL, we were able to accordingly alter the lipolytic rates
in adipocytes.
G0S2 was previously shown to be localized to the endo-
plasmic reticulum (ER) when expressed in HEK293 cells as
well as 3T3-L1 preadipocytes (Zandbergen et al., 2005). ATGL,
on the other hand, was found to be tightly associated with
membranes when not localized to lipid droplets in HeLa cells
(Soni et al., 2009). Therefore, it is possible that, in adipocytes,
both G0S2 and ATGL also occur in association with an ER-
related membrane compartment, from which they are recruited
onto lipid droplets upon adrenergic stimulation. In this regard,Ceit would be interesting to determine whether coatmer protein I
(COPI) complex, the membrane-trafficking machinery respon-
sible for delivering ATGL to lipid droplets in nonadipocytes
(Beller et al., 2008; Soni et al., 2009), is also employed for lipid
droplet recruitment of ATGL and G0S2 in adipocytes.
Lastly, we found that G0S2 expression was significantly
reduced in WAT of db/db mice and high-fat-fed wild-type
mice. Because obesity is associated with insulin resistance in
peripheral tissues, we speculate that impaired insulin sensitivity
of adipocytes may lead to the decreased expression of G0S2. It
is also possible that increased production of TNFa by WAT
during obesity plays a role in downregulating G0S2 expression,
considering that G0S2 level was diminished in adipocytes
upon TNFa treatment (Figure 1D). Moreover, elevated basal
lipolytic capacity of adipocytes is known to contribute to
increased plasma FFA levels in human obesity (Boden and Shul-
man, 2002; Guilherme et al., 2008; Watt and Steinberg, 2007)
and thus may represent an important risk factor for the develop-
ment of insulin resistance and type 2 diabetes. Accordingly,
further studies will be undertaken to investigate whether expres-
sion of G0S2 is also decreased in obese human. If so, it would
be important to determine whether a reduced level of G0S2
contributes to the elevated lipolysis associated with obesity.EXPERIMENTAL PROCEDURES
Production and Purification of Bacterially Expressed G0S2
The full-length mouse G0S2 cDNA was subcloned by standard PCR into
pET41a MBP vector (Lu et al., 2008) to produce the protein fused with MBP
at the N-terminal end with the TEV cleavage site. For tag-free protein purifica-
tion, G0S2 was overexpressed in Escherichia coli BL21-Gold (Novagen) with
induction of 0.5 mM IPTG at an A600 of 0.8–1.0 at 37C and harvested after
culturing for an additional 4–6 hr. The cells were lysed by sonication, and the
expressed MBP-fusion proteins were isolated in the presence of 0.6 M NaCl
to prevent nonspecific binding to bacterial DNA. G0S2 was released by TEV
digestion from amylase magnetic beads (New England Biolabs) after overnight
incubation at 4C and further purified by ion exchange chromatography
(Mono-S FPLC). The purified protein was estimated to be at least 98%
pure as judged by staining with Coomassie brilliant blue on an 8%–25%
gradient SDS-polyacrylamide gel. Fractions were pooled; concentrations
were measured by UV absorption and dialyzed into PBS buffer containing
0.25 M sucrose, 1 mM EDTA, and 1 mM DTT.ll Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc. 203
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The following double-stranded stealth siRNA oligonucleotides (Invitrogen)
were used: set 1 for mouse G0S2, sense 50-CAUGCUGUUUCAAGGUGCCA
CCGAA-30, antisense 50-UUCGGUGGCACCUUGAAACAGCAUG-30; set 2 for
mouse G0S2, sense 50CACCGAAUCCAGAACUGACCCUACA-30, antisense
50-UGUAGGGUCAGUUCUGGAUUCGGUG-30; human ATGL, set of three
validated siRNA oligonucleotides (cat# 1299003); mouse ATGL, set of three
validated oligonucleotides (cat# 1320003). Control oligonucleotides with
comparable GC content were also from Invitrogen.
For ATGL knockdown in HeLa cells, total 100 pmol of mixed oligonucleo-
tides, 33 pmol of each of the three sets, were transfected into HeLa cells plated
in 6-well dishes using Lipofectamine 2000. For ATGL and G0S2 knockdown in
3T3-L1 adipocytes, 4 nmol of mixed oligonucleotides, 2 nmol of each of the
three sets, were delivered into cells via electroporation using BioRad Gene
Pulser II at 950 mF and 160V, as described previously (Chen et al., 2007). After
3 days of incubation, cells were processed for designated assays.
Adenoviral Infection of Adipocytes and Adipose Tissue Explants
Recombinant adenovirus containing murine G0S2 cDNA under the control of
a CMV promoter (Ad-G0S2) was custom generated by Vector Biolabs. A
CMV null virus (Ad null) was also obtained for use in control experiments. Infec-
tion of differentiated adipocytes and adipose tissue explants was performed
by using a previously published method (Greenberg et al., 2003) with minor
modifications. For infection of 3T3-L1 adipocytes, Ad-G0S2 or Ad null were
diluted to two concentrations (107 and 108 pfu/ml) in DMEM, 2% FBS, and
5.0 mg/ml polybrene and preincubated for 45 min at room temperature. Adipo-
cytes in 6-well dishes were washed once with PBS, and 1.2 ml of preincubated
virus mix was added to each well. Cells were centrifuged at 800 3 g for 1 hr
at room temperature followed by incubation at 37C. Fresh growth medium
(1.0 ml/well) was added after 4 hr, and cells were incubated for 48–72 hr
before use. For infection of adipose tissue explants, gonadal fat pads (25 mg)
freshly isolated from 20-week-old C57BL6 female mice were washed with
PBS and then incubated in a microcentrifuge tube containing 150 ml of virus
mix (7 3 108 pfu/ml) for 45 min at room temperature. Following centrifugation
at 800 3 g for 1 hr at room temperature, explants along with virus mix
were transferred to a 24-well dish and incubated at 37C. Fresh growth
medium (0.5 ml/well) was added after 4 hr, and explants were incubated for
48 hr before use.
Lipid Droplet Fractionation
Lipid droplets were isolated from 3T3-L1 adipocytes as describe previously
(Brasaemle and Wolins, 2006). In brief, cells were collected in ice-cold PBS
followed by centrifugation for 10 min at 10003 g, 4C. Cell pellets were resus-
pended in HLM buffer (20 mM Tris$Cl [pH 7.4], 1 mM, 0.5 mM EDTA, 10 mM
sodium fluoride, and protease inhibitors) and homogenized by 10 gentle
strokes with a hand-driven pestle. The homogenates were centrifuged for
10 min at 10003 g, 4C. The supernatant was collected, and the floating lipid
layer was transferred into a separate ultracentrifugation tube. One-third volume
of ice-cold HLM containing 60% sucrose (final 20% sucrose) was added, and
lipid droplets were mixed thoroughly by gentle pipetting. The mixture was
then overloaded sequentially with HLM containing 5% sucrose and HLM con-
taining no sucrose. After centrifugation for 30 min at 28,000 3 g, 4C, the
floating lipid droplet fraction was collected by using a Beckman tube slicer.
Equal volume of 10% SDS was added, and proteins associated with lipid drop-
lets were solubilized by incubation for 2 hr at 37C in a sonicating water bath.
Assay for TAG Hydrolase Activity
For assays with HeLa cell extracts, cells in 10 cm dishes were washed twice in
ice-cold PBS and then disrupted on ice by passing 10 times through a 22G
needle in 0.5 ml of cell extraction buffer (0.25 M sucrose, 1 mM EDTA, 1 mM
DTT, and protease inhibitors [1 mini tablet per 7 ml of volume]). For assays
with WAT and BAT, epididymal and interscapular fat pads were homogenized
in cell extraction buffer by a drill press as described above. The cell and tissue
extracts were clarified by centrifugation at 1000 3 g for 15 min. The TAG
hydrolase activity against 3H-labeled triolein was measured as described
previously (Lass et al., 2006; Zimmermann et al., 2004) by mixing 0.1 ml of
extracts with 0.1 ml of substrate solution. For assays using in vitro transcrip-
tion/translation products, a total of 35 ml of reaction mixture was prediluted204 Cell Metabolism 11, 194–205, March 3, 2010 ª2010 Elsevier Inc.with 65 ml of cell extraction buffer. The resulting 0.1 ml of reaction mixture
was then combined with 0.1 ml of substrate solution in the TAG hydrolase
activity measurement.
Lipolysis Assay and Measurement of Intracellular TAG Content
Lipolysis was measured as the rate of glycerol and free fatty acid release. In
brief, adipocytes or gonadal WAT explants in 12-well dishes were incubated
in 1 ml of assay buffer in the presence or absence of 1 mM isoproterenol.
Aliquots of assay buffer were collected over a 30 min–2 hr period. The amounts
of glycerol and FFAs released were determined by using a lipolysis assay kit
(Zenbio) according to the manufacturer’s instructions. Lysates were then
prepared from the remaining cells, and protein concentrations in the lysates
were used to normalize the lipolytic signals.
Triglyceride accumulation was measured using a triglyceride assay kit
(Zenbio). In brief, at the indicated time after oleic acid treatment, HeLa cells
were washed and lysed in provided lysis buffer. Then the triglyceride assay
reagents were added according to the manufacturer’s instructions. The optical
density of the solution was measured at 540 nm using a spectrophotometer
plate reader. TAG concentration was calculated from a standard curve for
each assay, and data is normalized to total cellular protein.
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